Navigation Links
Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market.

GOTHENBURG, Sweden, December 3 /PRNewswire/ -- Cellectricon, a leading provider of screening solutions for drug discovery, today announced the signing of a collaborative agreement with The Automation Partnership (TAP) in the UK, manufacturers of advanced automated systems for cell culture, sample management and high throughput screening applications. Under the agreement TAP will co-develop and manufacture the Dynaflow(R)HT System, Cellectricon's next generation high throughput ion channel screening platform. Dynaflow(R)HT will be launched and commercially available in 2009.

Addressing the limitations of current ion channel screening technologies, the Dynaflow(R)HT yields an unmatched level of automated throughput while still delivering unique measurement data quality. The concept and technology has been developed and validated over the last three years by Cellectricon in partnership with AstraZeneca.

"We are excited to partner with TAP who are world-renowned for manufacturing industrial quality automation," says Jonas Ohlsson, CEO at Cellectricon. "To bring this fully automated state-of-the-art high throughput electrophysiology system to the market is a milestone for ion channel screening. The system offers unmatched throughput, cost per data point and reliability/predictability."

"The Automation Partnership (TAP) are very pleased to have the opportunity to work with Cellectricon in automating their unique high throughput microfluidic screening platform," says Andy Morffew Chief Executive Officer. "We are looking forward to supporting this system with a wide range of excellent technical and professional services, designed to ensure customers gain optimum return from their capital investment."

About Cellectricon

Cellectricon AB, a Swedish biotech company, successfully provides groundbreaking products to the pharmaceutical and biotechnology industries. The company utilizes state-of-the-art interfaces to biological systems by employing novel microfluidic technologies. This enables completely new types of assays and devices with superior performance characteristics and robustness. Cellectricon's products address critical bottlenecks in the drug discovery process and have been adopted by top-reference customers, including nine of the top ten pharmaceutical companies. In 2007, the company increased its annual revenue by almost 50%. In 2008-2009 the company is launching two pioneering large-scale screening platforms developed in close collaboration with leaders in the pharmaceutical industry. Used in pre-clinical pharmaceutical development, the Cellaxess(R)HT System enables high throughput RNAi screening and the Dynaflow(R)HT System greatly advances ion channel drug discovery.

About The Automation Partnership

The Automation Partnership (TAP) is a world leader in the design, development and implementation of advanced automation systems for the life sciences research industry. TAP specializes in automation for cell culture, sample management and advanced screening applications. These range from multi-million pound large-scale drug discovery facilities to standalone bench-top products. TAP also offers custom engineering services to customers requiring unique solutions for complex and challenging research problems.

TAP's customers include the world's top pharmaceutical and biotechnology companies, key service providers and leading research institutions including: Amgen, AstraZeneca, ATCC, GlaxoSmithKline, Loughborough University, Max Planck Institute, Merck, Oxford University, Stem Cell Sciences, UK Biobank and Wyeth.

    Contact Cellectricon:

    Jonas Ohlsson, CEO
    Phone: +46(0)709-73-47-92

    Susanne Fagerlund, VP Marketing & Communications
    Phone: +46(0)31-760-35-15

    Contact The Automation Partnership:

    Matthew Walker, Head of Communications
    Phone: +44(0)1763-22-72-00

SOURCE Cellectricon AB
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Share Issue Gives Cellectricon SEK 89 Million to Continue its Rapid Market Expansion
2. Cellectricon and AstraZeneca - Partners in New High Throughput Ion Channel Drug Discovery Technology
3. Cellectricon Receives Milestone Order for Cellaxess(R)HT, the Worlds First High Throughput RNAi Screening System
4. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
5. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
6. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
10. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
11. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... SICM Module, an add-on scanning ion conductance microscopy module to Park NX10 that ... an AFM. , Park SICM benefits virtually all materials characterization that require measurements ...
(Date:12/1/2015)... SAN FRANCISCO , Dec. 1, 2015  Symic, ... and affect the extracellular matrix (ECM), today announced that ... financing to advance the company,s pipeline, including its lead ... Lilly Ventures and includes the participation by all existing ... new funding brings the total capital raised by Symic ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... global meeting this month and Dr. J. Kyle Mathews will join ... includes the new single site hysterectomy. , An experienced urogynecologist, founder of Plano ...
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem ... and aesthetics professionals from Central America and abroad for the first Iberoamerican Convention ... Panama Feb. 17-19, 2016. Testart will present and discuss new trends in anti-aging ...
Breaking Biology Technology:
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
(Date:11/12/2015)... Nov. 12, 2015  Arxspan has entered into ... and Harvard for use of its ArxLab cloud-based ... tools. The partnership will support the institute,s efforts ... chemical research information internally and with external collaborators. ... for managing the Institute,s electronic laboratory notebook, compound ...
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
Breaking Biology News(10 mins):